Valuation: Sagittarius Life Science Corp

Market Cap 2.57B 77.96M 71.01M 65.43M 59.52M 112M 7.22B 117M 796M 317M 3.94B 293M 286M 12.38B P/E 2024
-21.4x
P/E 2025 -55.9x
Enterprise Value 1.77B 53.6M 48.82M 44.98M 40.92M 76.76M 4.96B 80.68M 547M 218M 2.71B 201M 197M 8.51B EV / Sales 2024
1.9x
EV / Sales 2025 7.69x
Free-Float
29.82%
Yield 2024 *
-
Yield 2025 -
Nov. 13 Sagittarius Life Science Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 CI
Aug. 14 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
May. 14 Sagittarius Life Science Corp Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
Mar. 16 Sagittarius Life Science Corp Reports Earnings Results for the Full Year Ended December 31, 2025 CI
Nov. 13 Sagittarius Life Science Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-08-12 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-05-14 Sagittarius Life Science Corp Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-03-12 Sagittarius Life Science Corp Reports Earnings Results for the Full Year Ended December 31, 2024 CI
24-11-13 Sagittarius Life Science Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
24-08-13 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
24-05-14 Sagittarius Life Science Corp Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
24-03-21 Sagittarius Life Science Corp Reports Earnings Results for the Full Year Ended December 31, 2023 CI
23-11-13 Sagittarius Life Science Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
1 day-6.51%
1 week-15.07%
Current month-16.83%
1 month-18.70%
3 months-21.14%
6 months-29.01%
Current year-25.83%
1 week 38
Extreme 38.00000000
44.5
1 month 38
Extreme 38.00000000
46.8
Current year 38
Extreme 38.00000000
67
1 year 38
Extreme 38.00000000
67
3 years 21.3
Extreme 21.3
67
5 years 20.65
Extreme 20.65
79.2
10 years 20.65
Extreme 20.65
150
Manager TitleAgeSince
Chief Executive Officer - 2019-09-29
Director of Finance/CFO - 2019-11-14
Director TitleAgeSince
Chairman - 2004-04-28
Director/Board Member - 2015-06-16
Director/Board Member - 2004-04-28
Change 5-day change 1-year change 3-year change Capi.($)
-6.51%-15.07%-14.88%-21.30% 83.22M
+1.30%-1.18%+7.72%-13.58% 258B
+0.90%-0.42%+18.19%-6.16% 83.15B
+0.74%-0.90%-12.08%+18.67% 47.86B
+0.82%+1.26%-3.84%-10.47% 34.98B
-0.27%-5.66%+14.98%-9.48% 31.95B
-0.52%+4.53%-4.10%-4.86% 31.17B
+1.34%+7.58%+12.75%+23.75% 31.19B
+1.89%+3.72%+1.93%-24.57% 29.5B
+1.58%+4.99%+3.74%+8.81% 26.95B
Average -0.14%-1.11%+2.44%-3.92% 57B
Weighted average by Cap. +0.86%-1.06%+6.43%-6.41%

Financials

2024 2025
Net sales 468M 14.19M 12.92M 11.91M 10.83M 20.32M 1.31B 21.36M 145M 57.6M 718M 53.24M 52.11M 2.25B 346M 10.5M 9.56M 8.81M 8.01M 15.04M 972M 15.8M 107M 42.62M 531M 39.39M 38.56M 1.67B
Net income -48.53M -1.47M -1.34M -1.24M -1.12M -2.11M -136M -2.22M -15.04M -5.98M -74.46M -5.52M -5.41M -234M -49.56M -1.5M -1.37M -1.26M -1.15M -2.15M -139M -2.26M -15.36M -6.1M -76.04M -5.64M -5.52M -239M
Net Debt -150M -4.55M -4.15M -3.82M -3.48M -6.52M -422M -6.86M -46.52M -18.49M -230M -17.09M -16.73M -723M -803M -24.36M -22.19M -20.45M -18.6M -34.89M -2.26B -36.67M -249M -98.91M -1.23B -91.41M -89.48M -3.87B
Projected Income Statement - Annual - Sagittarius Life Science Corp
Logo Sagittarius Life Science Corp
Sagittarius Life Science Corp. is a Taiwan-based company principally engaged in the research, development, production and sales of health products. The Company's main products include various types of nutrition and health formulations, natural and organic food, beverages, probiotic fermentation products, beauty care ingredients, Chinese herbal medicines, plant new medicines and health supplies. The Company also provides related technical services for the research and development of Chinese and western pharmaceutical products. The Company distributes its products in domestic market and to overseas markets, such as the rest areas of Asia and the Americas.
Employees
112
Date Price Change Volume
26-11-20 NT$38.05 -6.51% 106,858
26-11-19 NT$40.70 -3.55% 67,878
26-11-18 NT$42.20 -0.71% 51,400
26-11-17 NT$42.50 -0.82% 45,014
26-11-16 NT$42.85 -3.38% 46,249
  1. Stock Market
  2. Stocks
  3. 3205 Stock